Radiology: Experts debate safety of x-ray scanning at U.S. airports

On March 11, the Transportation Security Administration (TSA) announced that it would re-test 247 x-ray scanners in use at U.S. airports after maintenance checks indicated that the devices emitted radiation doses 10 times higher than expected. As the agency attempts to untangle the matter and a March 16 Congressional hearing focuses on the TSA and whole-body imaging, experts weighed in on the potential health risks posed by backscatter x-ray screening in the April issue of Radiology.

David J. Brenner, PhD, from the Center for Radiological Research at Columbia University in New York City, argued that while the extensive deployment of x-ray backscatter scanners is likely safe for most individual passengers, it presents long-term population concerns. Meanwhile, David A. Schauer, ScD, from the National Council on Radiation Protection and Measurements (NCRP) of Bethesda, Md., suggested that extrapolating very small individual risks to large populations distorts risk.

Both authors agreed that millimeter wave technology provides a viable alternative to backscatter scanners because it entirely eliminates radiation at the same cost and functionality as x-ray scanning.

In December 2009, in response to the “Underwear Bomber,” the TSA bolstered its advanced imaging technology (AIT) program and recommended the use of AIT as a primary screening method at U.S. airports. The new policy could translate into one billion whole-body scans annually.

“The effective doses [associated with backscatter scanners] are extremely low, of the order of 1 uSv (microsievert),” offered Brenner. The 1 uSv figure is based on a mathematical formula to estimate dose rather than tests of actual backscatter x-ray systems, according to a spokesperson from the Radiological Society of North America (RSNA). Manufacturers of the scanners claim that the equipment meets the lower 0.1 uSv threshold established by NCRP.

However, recent TSA maintenance checks indicating potential discrepancies may mean that doses are higher than the 0.1 uSv threshold.

Risk is ambiguous as well. Brenner acknowledged, “We do not know with any certainty the magnitude of individual cancer risks associated with such low doses.”

Nevertheless, Brenner relied on a standard cancer mortality risk of 5 percent per sievert to estimate a 10-7 lifetime cancer mortality for a trip involving two 1 uSv security screens, while recognizing the major uncertainties associated with such low level exposure. Brenner referred to arguments that individual risk at extremely low doses is zero. Also, he pointed to indicators that “suggest that low-dose radiation risks could be higher than those anticipated on the basis of extrapolating risks estimated at higher doses.”

According to Brenner’s extrapolation, one billion annual scans at individual cancer risk per scan of 10-7 could result in 100 cancers. A “risk of 10-7 multiplied by 109 exposures no longer represents a trivial population risk,” he wrote.

In a second Radiology article on the topic, Schauer referred to the primary objectives of radiation protection: justification, optimization and limitation, while advocating for strict regulatory control of backscatter scanners to ensure use consistent with these principles.

The NCRP, he noted, recommends an administrative control of 0.25 mSv effective dose per year be employed for individuals undergoing security screening. The council also stated that general use backscatter systems adhere to an effective dose of 0.1 uSv or less per scan. About the exposure, he suggested that “such systems can be used without regard to the number of scans per individual in a year.”

As TSA re-checks equipment and Congress mulls health concerns and other issues related to backscatter x-ray security scanning, Schauer concluded. “The time is right for countries like the United States to take a comprehensive look at the use of x-rays for medical and nonmedical imaging applications to ensure their use is consistent with the goals and objectives of radiation protection.”

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup